Similarly, the combined use of anti-CD36 antibody to inhibit the Treg-specific up-regulation of CD36 with anti-PD-1 treatment strengthens the anti-tumor response induced by the anti-CD36 antibody alone without causing any autoimmunity [98]. Here, CD36 is linked to neoplasm.